Apollomics Inc (NASDAQ:APLM) shares are trading higher by 17.6% to $0.24 during Wednesday's session after the company late Tuesday announced it had received approval from Nasdaq for a 180-day extension to address non-compliance with its listing requirements due to its share price falling below $1.00 for an extended period.

The extension allows Apollomics until January 13, 2025 to regain compliance by achieving a minimum bid price of $1.00 per share for at least ten consecutive business days. Failure to meet this requirement by the deadline could result in delisting from Nasdaq, although the company can appeal this decision if necessary.

Apollomics says the company plans to closely monitor its share prices and explore options to meet the listing criteria.

Read Also: Semiconductors Suffer Worst Selloff In Years On Stricter US Chip Exports To China

How To Buy APLM Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Apollomics' case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, APLM has a 52-week high of $6.20 and a 52-week low of $0.18.